The abstract is read at the publisher; the summary is JClub's.
The New Vaccine Surveillance Network (NVSN) has, over 25 years, built an active, population-based pediatric surveillance system in the United States that quantifies ARI and AGE burden.
- Why it matters: Reliable, real-world evidence is needed to track pediatric infectious disease burden, assess vaccine performance, and detect emerging threats and unexpected outcomes.
- What they did: Since 1999, NVSN prospectively collects clinical, epidemiologic, and laboratory data from US children seeking care for acute respiratory infections and acute gastroenteritis across multiple healthcare settings.
- The result: The network has established the burden of ARI and AGE, demonstrated effectiveness of licensed pediatric vaccines, and supports evaluation of preventive measures and emerging infections like enterovirus D-68 and severe acute respiratory syndrome coronavirus 2.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.